Regeneron, Mammoth Launch In Vivo CRISPR Gene Editing Collaboration
Regeneron Pharmaceuticals will use Mammoth Biosciences’ CRISPR-based ultracompact gene editing platform to develop in vivo therapies for tissues and cell types beyond the liver.
Regeneron Pharmaceuticals will use Mammoth Biosciences’ CRISPR-based ultracompact gene editing platform to develop in vivo therapies for tissues and cell types beyond the liver.
Nature – A transient perturbation of transcriptional silencing mediated by Polycomb proteins is sufficient to induce an epigenetic cancer cell fate in Drosophila in the…
Nature Reviews Genetics – A study in Nature finds that transient perturbation of the Polycomb complex and target epigenome can irreversibly induce cancer cell fates.
To build on the success of monospecific antibodies, drug developers are exploring the possibilities offered by bi-, tri-, and even tetraspecific antibodies.
Nature Biotechnology – The genome-wide landscape of Cas-induced double-strand breaks and end structures is profiled at nucleotide resolution.
CAP1 affects neuronal morphology through cytosolic retention of an actin-regulated transcription cofactor.
May is Mental Health Awareness month: How can employers help workers feel connected?
For over a decade, I worked as a nurse in a Primary Stroke Center caring for critically ill cardiac and stroke patients. | Nurses—and the…
Your words have the power to make someone feel seen, heard, and loved, says Stephanie Harrison, author of “New Happy.” Here are 10 phrases to…
Nature – Google scientists have modelled a fragment of the human brain at nanoscale resolution, revealing cells with previously undiscovered features.
Lyrics to English-language top hits have become less complex and more repetitive, which may make them catchier—and more appealing